171 related articles for article (PubMed ID: 37504084)
1. Early Screening of Colorectal Precancerous Lesions Based on Combined Measurement of Multiple Serum Tumor Markers Using Artificial Neural Network Analysis.
Ke X; Liu W; Shen L; Zhang Y; Liu W; Wang C; Wang X
Biosensors (Basel); 2023 Jun; 13(7):. PubMed ID: 37504084
[TBL] [Abstract][Full Text] [Related]
2. Serum macrophage inhibitory cytokine-1 serves as a novel diagnostic biomarker of early-stage colorectal cancer.
Dai C; Zhang X; Ma Y; Chen Z; Chen S; Zhang Y; Li M
Biomarkers; 2021 Nov; 26(7):598-605. PubMed ID: 34266319
[TBL] [Abstract][Full Text] [Related]
3. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
[TBL] [Abstract][Full Text] [Related]
4. Artificial neural network-based diagnostic models for lung cancer combining conventional indicators with tumor markers.
Luo Y; Yuan H; Pei Q; Chen Y; Xian J; Du R; Ye T
Exp Biol Med (Maywood); 2023 May; 248(10):829-838. PubMed ID: 37403334
[TBL] [Abstract][Full Text] [Related]
5. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
6. Application of Artificial Neural Network in miRNA Biomarker Selection and Precise Diagnosis of Colorectal Cancer.
Afshar S; Afshar S; Warden E; Manochehri H; Saidijam M
Iran Biomed J; 2019 May; 23(3):175-83. PubMed ID: 30056689
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer].
Xue Z; Lu J; Lin J; Huang CM; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Zheng CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):327-335. PubMed ID: 35461201
[No Abstract] [Full Text] [Related]
8. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
[TBL] [Abstract][Full Text] [Related]
9. The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.
Feng F; Wu Y; Wu Y; Nie G; Ni R
J Med Syst; 2012 Oct; 36(5):2973-80. PubMed ID: 21882004
[TBL] [Abstract][Full Text] [Related]
10. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive prediction of microsatellite instability in colorectal cancer by a genetic algorithm-enhanced artificial neural network-based CT radiomics signature.
Chen X; He L; Li Q; Liu L; Li S; Zhang Y; Liu Z; Huang Y; Mao Y; Chen X
Eur Radiol; 2023 Jan; 33(1):11-22. PubMed ID: 35771245
[TBL] [Abstract][Full Text] [Related]
12. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
13. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of multiple biological indicators for the combined diagnosis of metastases from colorectal cancer-a retrospective study based on 1163 patients.
Chen B; Zhou J; Ma Y; Sun Q; Ren J; Wang D
World J Surg Oncol; 2023 Jul; 21(1):229. PubMed ID: 37501060
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.
Gu Y; Duan B; Sha J; Zhang R; Fan J; Xu X; Zhao H; Niu X; Geng Z; Gu J; Huang B; Ren S
Int J Cancer; 2023 Feb; 152(3):536-547. PubMed ID: 36121650
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
18. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45.
Lim DH; Lee JH; Kim JW
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28186354
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-372 is a Diagnostic and Prognostic Biomarker in Patients with Early Colorectal Cancer.
Yu J; Jin L; Jiang L; Gao L; Zhou J; Hu Y; Li W; Zhi Q; Zhu X
Anticancer Agents Med Chem; 2016; 16(4):424-31. PubMed ID: 26179262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]